rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-6-10
|
pubmed:abstractText |
Antiphospholipid syndrome (APS) is characterized by thrombosis (venous and arterial) and pregnancy loss in conjunction with the lupus anticoagulant, IgG or IgM anticardiolipin, or IgG or IgM anti-beta2-glycoprotein I. In most series, only a minority of patients with antiphospholipid antibodies develop a clinical manifestation.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1195-9
|
pubmed:meshHeading |
pubmed-meshheading:19447935-Abortion, Habitual,
pubmed-meshheading:19447935-Adult,
pubmed-meshheading:19447935-Antiphospholipid Syndrome,
pubmed-meshheading:19447935-Arteries,
pubmed-meshheading:19447935-Brazil,
pubmed-meshheading:19447935-Cross-Sectional Studies,
pubmed-meshheading:19447935-Female,
pubmed-meshheading:19447935-Humans,
pubmed-meshheading:19447935-Hypertension,
pubmed-meshheading:19447935-Lupus Erythematosus, Systemic,
pubmed-meshheading:19447935-Male,
pubmed-meshheading:19447935-Pregnancy,
pubmed-meshheading:19447935-Retrospective Studies,
pubmed-meshheading:19447935-Risk Assessment,
pubmed-meshheading:19447935-Thrombophilia,
pubmed-meshheading:19447935-Triglycerides,
pubmed-meshheading:19447935-Venous Thrombosis,
pubmed-meshheading:19447935-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
|
pubmed:affiliation |
Rheumatology Department, Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 7500, Baltimore MD 21205, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|